Tirzepatide, a dual incretin analog, is a boon in metabolic syndrome: an editorial

Ann Med Surg (Lond). 2024 Feb 5;86(3):1249-1250. doi: 10.1097/MS9.0000000000001782. eCollection 2024 Mar.

¹ Miami Cancer Institute, Baptist Health South Florida, Miami, USA.
² Shree Chanakya Education Society's Indira College of Pharmacy, Pune.
³ Deputy Chief Inspector of Factories/ Deputy Director (Medical) and Certifying Surgeon, Directorate of Factories, Department of Labour, Government of West Bengal.
⁴ Department of Pharmacology, Manipal Tata Medical College Jamshedpur, Manipal Academy of Higher Education, Manipal, Karnataka, India.
⁵ B. P. Koirala Institute of Health Sciences, Dharan, Nepal.

No abstract available

Publication types